Pro Medicus (OTCMKTS:PMCUF) Shares Gap Down – Should You Sell?

Shares of Pro Medicus Limited (OTCMKTS:PMCUFGet Free Report) gapped down before the market opened on Monday . The stock had previously closed at $129.94, but opened at $118.20. Pro Medicus shares last traded at $118.20, with a volume of 15 shares traded.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group lowered shares of Pro Medicus from a “buy” rating to a “hold” rating in a research note on Wednesday, July 8th. One research analyst has rated the stock with a Hold rating, According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $155.00.

Check Out Our Latest Analysis on PMCUF

Pro Medicus Price Performance

The business has a fifty day moving average of $125.21 and a 200-day moving average of $105.80.

Pro Medicus Company Profile

(Get Free Report)

Pro Medicus Limited is an Australia‐based healthcare technology company specializing in advanced medical imaging IT solutions. Its core offerings include radiology information systems (RIS), picture archiving and communication systems (PACS), and enterprise imaging platforms designed to streamline diagnostic workflows and enhance image management for healthcare providers.

The company’s flagship product suite, Visage 7, delivers high-performance visualization and reporting capabilities, enabling radiologists to access and manipulate large datasets with minimal latency.

Featured Articles

Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.